Increasing awareness of cardiac manifestations of sarcoidosis and the widespread
availability of advanced imaging tests have led to a tidal wave of interest in a condition that …

Cardiac involvement is a major cause of morbidity and mortality in patients with sarcoidosis.
1, 2 Compared with many other manifestations of the disease, patients with cardiac …

Cardiac sarcoidosis (CS) frequently leads to ventricular tachycardia (VT), which is often
refractory to antiarrhythmic and/or immunosuppressive medications and requires catheter …

Sarcoidosis in Japanese sarcoidosis is characterized by a high prevalence of cardiac
involvement. In this regard, cardiac sarcoidosis (CS) continues to be an important focus of …

Sarcoidosis is a systemic disease characterized by noncaseating granulomas and is often a
diagnosis of exclusion. The actual prevalence of cardiac sarcoidosis (CS) is unknown, as …

Purpose Cardiac sarcoidosis is a multisystem inflammatory disorder characterized by
ventricular arrhythmias. Implantable cardioverter defibrillator (ICD) is used to prevent …

Introduction: Those with cardiac sarcoidosis (CS) are at risk of sudden cardiac death (SCD),
which may be prevented using an implantable cardioverter–defibrillator (ICD). There are …

Cardiac sarcoidosis (CS) is a complex disease that can manifest as a diverse array of
arrhythmias. CS patients may be at higher risk for sudden cardiac death (SCD), and, in some …

Introduction Sarcoidosis is a systemic inflammatory disorder associated with ventricular
arrhythmias (VAs) and sudden death in the context of cardiac involvement. Guidelines …

Objective: Cardiac involvement in sarcoidosis can present in various ways, with
atrioventricular (AV) block and ventricular arrhythmias being the most common signs …